Quanterix Corporation (Nasdaq: QTRX), based in Billerica, Massachusetts, will participate in the Goldman Sachs 47th Annual Global Healthcare Conference scheduled for June 8-10, 2026, in Miami, Florida. During the event, CEO Everett Cunningham will host a fireside chat on June 9 at 1:20 pm ET, where he will discuss the company's latest updates and strategic priorities. Quanterix is recognized for its pioneering Simoa® technology, which enables the detection of biomarkers in blood and other fluids at unprecedented sensitivity levels. With around 6,500 peer-reviewed publications, the company has established itself as a key player in disease research and diagnostics. In 2025, Quanterix expanded its offerings by acquiring Akoya Biosciences, which specializes in multiplexed tissue imaging, thereby enhancing its integrated platform for advancing precision medicine. Investors can access the live webcast of the presentation through the company's Investor Relations section, with a replay available afterward.